[go: up one dir, main page]

CN109666625A - Single celled method is separated from tissue - Google Patents

Single celled method is separated from tissue Download PDF

Info

Publication number
CN109666625A
CN109666625A CN201811595502.8A CN201811595502A CN109666625A CN 109666625 A CN109666625 A CN 109666625A CN 201811595502 A CN201811595502 A CN 201811595502A CN 109666625 A CN109666625 A CN 109666625A
Authority
CN
China
Prior art keywords
tissue
digestion
sample
deoxyribonuclease
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811595502.8A
Other languages
Chinese (zh)
Inventor
吴文铭
彭俊雅
陈澔
黄丹
刘路路
洪夏飞
丛林
李冬晶
赵玉沛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Original Assignee
Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking Union Medical College Hospital Chinese Academy of Medical Sciences filed Critical Peking Union Medical College Hospital Chinese Academy of Medical Sciences
Priority to CN201811595502.8A priority Critical patent/CN109666625A/en
Publication of CN109666625A publication Critical patent/CN109666625A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to unicellular separation field, discloses and separate single celled method from tissue.It is digested the described method includes: tissue sample is mixed with digestive juice, the digestive juice contains VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease, wherein, the ratio between the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and the enzyme activity unit of deoxyribonuclease is 50-90:0.5-1:2000-5000:1.The present invention can realize that single celled high yield and high motility rate are extracted in the case where total digestion time is shorter, especially pancreatic tissue, capture the unicellular yield of existing pancreatic tissue and the lower problem of motility rate.

Description

Single celled method is separated from tissue
Technical field
The present invention relates to unicellular separation fields, and in particular to single celled method is separated from tissue.
Background technique
Pancreas is the organ that endocrine and exocrine function are had both in human body.It is thin comprising islet cells, acinus in histology Multiple cellular components such as born of the same parents, vessel cell and interstitial cell.Pancreas generates in the pancreatic juice of secretion containing trypsase, pancreas fat A variety of digestive ferments such as enzyme, amylopsin.With the rise of single cell analysis technology in recent years, people couple and human tissue organ Research is mixed from heterogeneity, and the global tissue analysis interfered with each other is gradually deep into the individual cells for constituting histoorgan Research, importance are self-evident.And in pancreas research field, due to pancreas organ's generally softness in fragile, histology Complicated component and it is easy to happen autodigestion because of potent pancreatin, so that pancreatic single cell research often stops at first Step --- namely the single celled acquisition of pancreatic tissue for analysis.
Human body or the unicellular separation method of animal model tissue organ are drawn from initial capillary, again to airflow classification To micro-fluidic technologies, numerous single-cell techniques more or less all achieves more satisfied knot in different tissues Fruit, but it is then barely satisfactory in pancreatic tissue.By consulting literatures it is found that researcher is slender in separating mouse cancer of pancreas at present When born of the same parents, the enzymic digestion dissociating method based on II Collagenase Type is mostly used greatly, and still, pancreatic single cell researcher indicates in pancreas Greatly challenge is encountered when the unicellular separation of gland or unicellular yield is not high or Cell viability is lower, therefore, exploitation The preparation or method for the pancreatic single cell that can be efficiently separated have particularly important meaning.
Summary of the invention
The purpose of the invention is to overcome the problems, such as that unicellular yield and Cell viability of the existing technology are lower, mention For separating single celled method in a kind of new slave tissue.
To achieve the goals above, the present invention provides one kind separates single celled method from tissue, this method comprises: Tissue sample is mixed with digestive juice and is digested, the digestive juice contains VIII Collagenase Type, neutral proteinase, trypsase Inhibitor and deoxyribonuclease, wherein the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxidation Ratio between the enzyme activity unit of ribalgilase is 50-90:0.5-1:2000-5000:1.
Through the above technical solutions, the present invention can realize single celled high yield in the case where total digestion time is shorter It is extracted with high motility rate, is based particularly on the unicellular separation of pancreatic tissue, has captured the unicellular yield of existing pancreatic tissue and work The lower problem of rate specifies direction for the single celled separation of pancreatic tissue, may advantageously facilitate to the further of pancreatic tissue Research.
Detailed description of the invention
Fig. 1 is to separate single celled result figure from pancreatic tissue using a kind of specific method;
Fig. 2 separates single celled result figure from pancreatic tissue using the method for specific embodiment according to the present invention;
Fig. 3 to Fig. 5 is to separate single celled result figure from pancreatic tissue using different reference methods respectively.
Specific embodiment
The endpoint of disclosed range and any value are not limited to the accurate range or value herein, these ranges or Value should be understood as comprising the value close to these ranges or value.For numberical range, between the endpoint value of each range, respectively It can be combined with each other between the endpoint value of a range and individual point value, and individually between point value and obtain one or more New numberical range, these numberical ranges should be considered as specific open herein.
In the present invention, in the absence of explanation to the contrary, term " enzyme activity unit " reaction used is that enzyme contains Amount number, refer under given conditions, converted in 1 minute in 1 micromole substrate or substrate needed for the related group of 1 micromole Enzyme amount, referred to as an enzyme activity unit (IU, also known as U).
Wherein, the definition of the enzyme activity unit of VIII Collagenase Type is: under conditions of pH 7.5 and 37 DEG C, hydrolysis in 5h It is an enzyme activity unit that collagen, which generates and is equivalent to the enzyme amount of the L-Leu of 1 μm of ol,.
The definition of the enzyme activity unit of neutral proteinase is: under conditions of pH 7.5 and 37 DEG C, hydrolyzing junket egg per minute The white enzyme amount for generating the Folin positive amino acid or peptide that are equivalent to 1 μm of ol tyrosine is an enzyme activity unit.
The definition of the enzyme activity unit of trypsin inhibitor is: can inhibit the vigor of a trypsase enzyme activity unit A referred to as inhibitor enzyme activity unit (U), under conditions of pH 7.5 and 25 DEG C, each second hydrolyzes the N- benzoyl-of 1 μm of ol L-arginine ethyl ester (BAEE) is a trypsase enzyme activity unit.
The definition of the enzyme activity unit of deoxyribonuclease is: under conditions of pH 8.0 and 37 DEG C, energy in 10 minutes Enzyme amount needed for the pBR322 Plasmid DNA of enough degradable 1 μ g is an enzyme activity unit.
It is provided by the invention that single celled method is separated from tissue includes: to mix tissue sample with digestive juice to disappear Change, the digestive juice contains VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease.
In the method, the ratio between VIII Collagenase Type and the enzyme activity unit of deoxyribonuclease is 50-90: 1, such as the arbitrary value between 50:1,52:1,55:1,60:1,65:1,70:1,75:1,80:1,85:1,90:1 or above-mentioned numerical value.
In the method, the ratio between neutral proteinase and the enzyme activity unit of deoxyribonuclease is 0.5-1:1, Such as 0.5:1,0.52:1,0.55:1,0.6:1,0.7:1:, the arbitrary value between 0.8:1,0.9:1,1:1 or above-mentioned numerical value.
In the method, the ratio between trypsin inhibitor and the enzyme activity unit of deoxyribonuclease is 2000-5000:1, as between 2000:1,2001:1,2010:1,2500:1,3000:1,4000:1,5000:1 or above-mentioned numerical value Arbitrary value.
Clostridiopetidase A is that unique one kind can degrade the protease of the natural collagen fibre with three strands of superhelixes, this Collagenous fibres are widely present in connective tissue.Clostridiopetidase A mainly by the fermented culture of clostridium histolyticum, is extracted, is refined And obtain, it can also extract and obtain from pig pancreas.In the present invention, the clostridiopetidase A is VIII Collagenase Type, for example, can be The Cat:C2139 of Sigma.
In the present invention, the specific type of neutral proteinase and deoxyribonuclease is not required particularly, Ke Yiwei The common various selections in this field.
Preferably, the neutral proteinase is Dispase II.For example, the Cat:4942078001 of Roche.
Preferably, the deoxyribonuclease is DNaseI.For example, the Cat:M0303S of NEB.
In the present invention, trypsin inhibitor can inhibit trypsase and chymotrypsin, prevent the active egg of other in pancreas The activation of white proenzyme and itself activation of trypsinogen, can choose trypsin inhibitor commonly used in the art.Example Such as, the Cat:T6522 of Sigma.
In the present invention, the digestive juice contains solvent.Relative to every milligram of VIII Collagenase Type, the content of the solvent Can be 0.1-12.5mL, preferably 0.2-3mL, as 0.2mL, 0.4mL, 0.5mL, 0.8mL, 1mL, 1.2mL, 1.3mL, Arbitrary value between 1.5mL, 2mL, 2.5mL or above-mentioned numerical value.
In the present invention, the solvent can be various common preservations or the reagent of dissolution enzyme preparation, it is preferable that described molten Agent is the phosphate buffer containing 4-10 volume % fetal calf serum.
In the present invention, the dosage of the digestive juice is not required particularly, as long as the sample can be submerged.It is excellent It is 1cm relative to volume in the case of choosing3Tissue sample, the dosage of the digestive juice is 10-60mL, as 10mL, 15mL, 20mL, 25mL, 26mL, 27mL, 28mL, 30mL, 32mL, 35mL, 40mL, 45mL, 50mL, 55mL, 60mL or above-mentioned numerical value it Between arbitrary value.
In the present invention, in order to preferably be digested, the volume of the tissue sample be preferably 1-2cm × 1-2cm × 0.5-2cm, such as 1.5cm × 1.5cm × 0.5cm.
In the present invention, the digestion can carry out under normal conditions.Preferably, the condition of the digestion includes that temperature is It is 35-38 DEG C, such as any between 35 DEG C, 36 DEG C, 36.5 DEG C, 36.8 DEG C, 37 DEG C, 37.2 DEG C, 37.5 DEG C, 38 DEG C or above-mentioned numerical value Value.
Preferably, the condition of the digestion further include the time be 5-80min, as 5min, 10min, 20min, 25min, 30min, 35min, 40min, 45min, 50min, 55min, 60min, 65min, 70min, 75min, 80min or above-mentioned numerical value it Between arbitrary value.
In the present invention, it is adhered pockets of treatments of the sample in order to further speed up, it can be with shear sample and/or by suction pipe (such as Wu Junbushi suction pipe) blows and beats sample.It filters after a period of time can also be digested through cell sieve, is mended into indigested sample Continue to digest after adding digestive juice.That is, the mode of the digestion can be with are as follows: mix sample with first part digestive juice, shear Sample, and the sample after shearing is mixed with second part digestive juice, sample is blown and beaten, cell sieve is crossed;Indigested sample is added Digestive juice continues digestion repeatedly, crosses cell sieve collection respectively and adds the digestion product obtained after digestive juice every time.Relative to volume For 1cm3Tissue sample, the dosage of first part's digestive juice can be 400-1000 μ L.It is 1cm relative to volume3Tissue sample Product, the dosage of second part digestive juice can be 5-20mL.It is 1cm relative to volume3Tissue sample, the digestion added every time The dosage of liquid can be 5-20mL.
In the present invention, in order to further promote the progress of digestion, the method also includes: before digestion, in tissue preserration Fiber, fat and the necrotic tissue of tissue sample are removed in liquid.
Wherein, the dosage of the tissue preserration liquid is not required particularly, as long as the sample can be submerged.Institute Stating tissue preserration liquid can be conventional selection, for example, can be the serum-free cell containing fetal calf serum and protease inhibitors Freezing media.
In the present invention, the method also includes: postdigestive sample is contacted with erythrocyte cracked liquid to crack red thin Born of the same parents obtain the unicellular of separation after washing.Postdigestive sample be cell suspending liquid, be centrifuged and take precipitating, precipitate with it is red Cell pyrolysis liquid is contacted to remove red blood cell.The dosage of the erythrocyte cracked liquid can be conventional selection, for example, relative to body Product is 1cm3Tissue sample, the dosage of the erythrocyte cracked liquid can be 3-8ml.Washing used washing lotion may be Conventional selection, for example, can be the phosphate buffer containing 0.02-0.08 weight % bovine serum albumin.To the washing lotion Dosage is not particularly limited, for example, being 1cm relative to volume3Tissue sample, the dosage of the washing lotion can be 3-8ml.
A kind of specific embodiment according to the present invention, the described method comprises the following steps:
1) in tissue preserration liquid, the fiber, fat and necrotic tissue etc. cut on tissue sample are pruned with Sterile ophthalmic;
2) sterile PBS washing;
3) sample is put into sterile centrifugation tube, it (is 1cm relative to volume that first part's digestive juice, which is added,3Tissue sample Product, the dosage of first part's digestive juice can be 400-1000 μ L);
4) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5 Minute;
5) tissue debris is transferred in sterile petri dish, it (is 1cm relative to volume that second part digestive juice, which is added,3's Tissue sample, the dosage of second part digestive juice can be 5-20mL);
6) it is blown and beaten using Wu Junbushi suction pipe, collects supernatant and cross cell sieve, take filtrate, indigested tissue debris, which is added, to disappear Change liquid to continue to digest in sterile petri dish, until tissue digestion is complete or obtains satisfied tissue monocytes (relative to volume For 1cm3Tissue sample, the dosage for the digestive juice added every time can be 5-20mL);
7) filtrate obtained in step 6) is centrifuged;
8) abandon supernatant, be added lysate softly blow and beat, be resuspended precipitating, be protected from light at room temperature split it is red, if there is cotton-shaped indissoluble object, Cell is crossed again weed out remove;
9) re-suspension liquid is transferred in sterile centrifugation tube and is centrifuged;
10) supernatant is abandoned, first part's washing lotion is added and softly blows and beats resuspension precipitating, it is meticulous again if there is cotton-shaped indissoluble object Born of the same parents, which weed out, to be removed, and re-suspension liquid is transferred to new sterile centrifugation tube and continuously adds second part washing lotion (first part's washing lotion and the The volume ratio of two part washing lotions can be 1:4-5);
11) it is centrifuged;
12) step 10) is repeated;
13) it is centrifuged.
In the present invention, the method can also include using cell culture medium to digesting resulting unicellular cultivate. The cell culture medium can be the conventional medium for expanding cell, or the dimensional culture base containing growth factor, So that the single cells grown obtained is three-dimensional organoid model.
In the present invention, the tissue sample can be common tissue sample, can be pancreatic samples, such as tumour place The normal pancreatic tissue at position.It is unicellular method of the invention is particularly suitable for being separated from pancreatic samples, therefore, according to this hair Bright preferred embodiment, the tissue sample are the normal pancreatic tissue at position where tumour.
The present invention will be described in detail by way of examples below.
Table 1
Table 2
Embodiment 1
The present embodiment is used to illustrate of the invention single from normal pancreatic tissue (Normal Pancreas at position where tumour) separation The method of cell, wherein used tissue preserration liquid, digestive juice, lysate and washing lotion are as shown in table 1, in every liter of digestive juice The enzyme activity unit value and concentration of each ingredient are as shown in table 2, and the preparation method of digestive juice are as follows: mixing VIII Collagenase Type, Dispase II and trypsin inhibitor dissolve mixing powder using solvent, add DNaseI mixing.
Sample is divided into five groups and is tested and (be shown in Table 3), specific steps are as follows:
1) in tissue preserration liquid, it is (normal that fiber, fat and necrotic tissue cut on sample etc. is pruned with Sterile ophthalmic Pancreatic tissue block size about 1.5 × 1.5 × 0.5cm3, color is yellow, and quality is medium partially soft, and surface is cut without black burnt necrosis, too many blood The visible clearly pancreas leaflet in face separates, and derives from pancreatic neoplasm patient, and operation cuts acquisition, patient's signed informed consent Book).
2) sterile PBS is washed 3 times.
3) sample is put into 5ml sterile EP tube (eppendorf), about 500 μ l of digestive juice is added.
4) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5 Minute.
5) tissue debris is transferred in 10cm sterile petri dish, 10ml digestive juice is added, be placed in 37 DEG C of incubator digestion.
6) it is mixed once every 5min using the piping and druming of Wu Junbushi suction pipe, and is seen under 10 × 20,10 × 40 power microscopes Examine cell dissociation situation.There is individual cells suspension in visible digestive juice under the microscope when first 10min, by digestive juice It is collected into sterile 50ml centrifuge tube together with tissue debris, is stood after soft piping and druming, collect supernatant and cross 40 μm of cell sieve (cell Strainer), filtrate is taken.Indigested tissue debris adds digestive juice 10ml and continues to digest in 10cm sterile petri dish, directly It completely or obtains that satisfied pancreas normal tissue is unicellular (altogether continue 50min) to tissue digestion, first 10min is collected Filtrate is given it up, and because it contains more impurity, separates unicellular difficulty.
The filtrate that later every 10min digests can retain respectively, carry out aftermentioned operating procedure respectively, and final choose is lived The optimal single cell suspension sample of rate, cell quantity.
7) filtrate 800g obtained in step 6) is centrifuged 4min (using horizontal rotor).
8) supernatant is abandoned, 5ml lysate is added and softly blows and beats, precipitating is resuspended, is protected from light splits red 5min (if there is cotton-shaped difficulty at room temperature Molten object then crosses 40 μm of cell sieve removals again).
9) re-suspension liquid is transferred in sterile 15ml centrifuge tube and is centrifuged, centrifugal force: 800g, time: 4min.
10) supernatant is abandoned, addition 1ml washing lotion softly blows and beats resuspension precipitating and (if there is cotton-shaped indissoluble object, crosses 40 μm of cells again Weed out and remove), re-suspension liquid is transferred to a new sterile 15ml centrifuge tube and continuously adds 5ml washing lotion.
11) 600g is centrifuged 5min.
12) step 10) is repeated.
13) 400g is centrifuged 6min.
14) supernatant is abandoned, precipitating is resuspended in appropriate washing lotion, and (precipitating of covering 15ml centrifugation bottom of the tube, uses 100 μ l washing lotion weights It is outstanding), take isometric cell and trypan blue to mix, microscopy cellular morphology, motility rate, impurity situation etc., cell counter (life Cell countess) detection Cell viability (living cells quantity accounts for the percentage of total number of cells in=every ml product) is (every with concentration Total number of cells in ml product, including dead cell), as a result as shown in Fig. 1-5 and table 3.
In Fig. 1-5, upper figure is the result figure for observing digestion effect after digesting under ordinary optical microscope (40 ×), the following figure For the result figure for observing Cell viability after further diluting under ordinary optical microscope (40 ×).
Table 3
From Fig. 2 and table 3 as can be seen that can effectively be separated from normal tissue using method of the invention it is unicellular, Basic soilless sticking, Cell viability are higher.Particularly, it will be seen from figure 1 that working as the ratio of the VIII Collagenase Type and DNaseI When value is improved to 100:1, unicellular yield and motility rate are higher, and therefore, the other embodiment of one kind according to the present invention is described Ratio between VIII Collagenase Type, neutral proteinase, trypsin inhibitor and the enzyme activity unit of deoxyribonuclease For 100:1:5000:1.For another angle, the test result based on I-1, those skilled in the art can be easy to pre- Phase when the VIII Collagenase Type, neutral proteinase, trypsin inhibitor and deoxyribonuclease enzyme activity unit it Between ratio method within the scope of the present invention can improve agglomeration, Cell viability can also effectively improve.
If can be seen that the ratio in digestive juice between each component not within the scope of the invention from Fig. 3 and table 3, Cell, which exists, after digestion reunites, and Cell viability is relatively low.
From Fig. 4 and table 3 as can be seen that can be obtained using VIII Collagenase Type more significantly more than other types of clostridiopetidase A Unicellular and Cell viability it is also higher.
From Fig. 5 and table 3 as can be seen that being only used cooperatively VIII Collagenase Type, neutral proteinase, trypsin inhibitor Single cells population (reuniting few) and Cell viability can be effectively improved with deoxyribonuclease, four kinds of ingredients are indispensable, Collaboration plays a role.
Embodiment 2
The present embodiment is used to illustrate of the invention from the single celled method of pancreas source tumor tissues separation, wherein is made Tissue preserration liquid, digestive juice, lysate and washing lotion are as shown in table 1, each in every liter of digestive juice (preparation method is with embodiment 1) The enzyme activity unit value and concentration of a ingredient are as shown in the I-1 of table 2.
14) it in tissue preserration liquid, is pruned with Sterile ophthalmic and cuts pancreatic neoplasm sample (1.5 × 1.5 × 0.5cm3, hand Art cuts acquisition, patient's signed informed consent form) on fiber, fat and necrotic tissue etc..
15) sterile PBS is washed 3 times.
16) sample is put into 5mL sterile EP tube (eppendorf), about 500 μ l of digestive juice is added.
17) it is cut using Sterile ophthalmic and tissue is cut into clast (about 2 × 2 × 1mm3), it operates on ice, shear time is no more than 5 minutes.
18) tissue debris is transferred in 50ml sterile tube, 15ml digestive juice is added, be placed in 37 DEG C, 50rmp/min shakes It is digested on bed.
19) pockets of tissue debris piping and druming will be adhered using Wu Junbushi suction pipe after 5min to mix.
20) continue to observe tissue clastic state after digesting 5min, if being still adhered agglomerating, repeatedly step 6) -7), if tissue Clast dispersion then continues to digest 20min, and total digestion time is no more than 30min.
21) digestion finishes, and stands 3min after reusing Wu Junbushi suction pipe piping and druming tissue debris, collects supernatant and cross 40 μm Cell sieve (cell strainer), obtains filtrate and is placed on ice.
22) indigested tissue adds 15ml digestive juice, continues after digesting 20min, uses Wu Junbushi suction pipe piping and druming group Clast is knitted, 40 μm of cell sieves is crossed together with digestive juice and tissue debris, obtains filtrate.
23) merge the filtrate obtained twice, 800g is centrifuged 4min (using horizontal rotor).
24) supernatant is abandoned, 5ml lysate is added and softly blows and beats, precipitating is resuspended, is protected from light splits red 5min (if having cotton-shaped at room temperature Indissoluble object then crosses 40 μm of cell sieve removals again).
25) re-suspension liquid is transferred in sterile 15ml centrifuge tube and is centrifuged, centrifugal force: 800g, time: 4min.
26) supernatant is abandoned, addition 1ml washing lotion softly blows and beats resuspension precipitating and (if there is cotton-shaped indissoluble object, crosses 40 μm of cells again Weed out and remove), re-suspension liquid is transferred to a new sterile 15ml centrifuge tube and continuously adds 5ml washing lotion.
27) 600g is centrifuged 5min.
28) step 13) is repeated.
29) 400g is centrifuged 6min.
30) supernatant is abandoned, precipitating is resuspended in appropriate washing lotion, and (precipitating of covering 15ml centrifugation bottom of the tube, uses 100 μ l washing lotion weights It is outstanding), take isometric cell and trypan blue to mix, microscopy cellular morphology, motility rate, impurity situation etc., cell counter (life Cell countess) Cell viability and concentration are detected, it is as a result similar to Example 1, it can be effectively using method of the invention Unicellular, basic soilless sticking is separated from tumor tissues, Cell viability is higher (50% or more);And if between each component Ratio cell exists not within the scope of the invention, after digestion reunites, Cell viability is relatively low;And use VIII Collagenase Type It is also higher that the unicellular and Cell viability more significantly more than other types of clostridiopetidase A can be obtained.In addition, lack it is a kind of at In the case where point, single cells population and Cell viability are undesirable, further illustrate that four kinds of ingredients are indispensable, and collaboration, which plays, to be made With.
The preferred embodiment of the present invention has been described above in detail, and still, the present invention is not limited thereto.In skill of the invention In art conception range, can with various simple variants of the technical solution of the present invention are made, including each technical characteristic with it is any its Its suitable method is combined, and it should also be regarded as the disclosure of the present invention for these simple variants and combination, is belonged to Protection scope of the present invention.

Claims (10)

1.一种从组织中分离单细胞的方法,其特征在于,该方法包括:将组织样品与消化液混合进行消化,所述消化液含有VIII型胶原酶、中性蛋白酶、胰蛋白酶抑制剂和脱氧核糖核酸酶,其中,所述VIII型胶原酶、中性蛋白酶、胰蛋白酶抑制剂和脱氧核糖核酸酶的酶活力单位之间的比值为50-90:0.5-1:2000-5000:1。1. A method for separating single cells from tissue, characterized in that the method comprises: mixing a tissue sample with a digestive solution for digestion, the digestive solution containing collagenase type VIII, neutral protease, trypsin inhibitor and Deoxyribonuclease, wherein the ratio between the enzymatic activity units of the collagenase type VIII, neutral protease, trypsin inhibitor and deoxyribonuclease is 50-90:0.5-1:2000-5000:1. 2.根据权利要求1所述的方法,其中,所述中性蛋白酶为Dispase II;2. The method of claim 1, wherein the neutral protease is Dispase II; 和/或,所述脱氧核糖核酸酶为DNaseI。And/or, the deoxyribonuclease is DNaseI. 3.根据权利要求1或2所述的方法,其中,相对于每毫克的VIII型胶原酶,所述消化液中溶剂的含量为0.1-12.5mL。3. The method according to claim 1 or 2, wherein the content of the solvent in the digestion solution is 0.1-12.5 mL per mg of collagenase type VIII. 4.根据权利要求3所述的方法,其中,所述溶剂为含有4-10体积%胎牛血清的磷酸盐缓冲液。4. The method of claim 3, wherein the solvent is a phosphate buffered saline containing 4-10 vol% fetal bovine serum. 5.根据权利要求1所述的方法,其中,相对于体积为1cm3的组织样品,所述消化液的用量为10-60mL。5. The method of claim 1, wherein the amount of the digestion solution is 10-60 mL relative to a tissue sample with a volume of 1 cm 3 . 6.根据权利要求1或5所述的方法,其中,所述组织样品的体积是1-2cm×1-2cm×0.5-2cm。6. The method of claim 1 or 5, wherein the volume of the tissue sample is 1-2 cm x 1-2 cm x 0.5-2 cm. 7.根据权利要求1所述的方法,其中,所述消化的条件包括:温度为35-38℃,时间为5-80min。7. The method according to claim 1, wherein the digestion conditions comprise: a temperature of 35-38° C. and a time of 5-80 min. 8.根据权利要求1所述的方法,其中,所述方法还包括:在消化前,于组织保存液中去除组织样品的纤维、脂肪和坏死组织。8. The method of claim 1, wherein the method further comprises removing fibrous, fatty and necrotic tissue from the tissue sample in a tissue preservation solution prior to digestion. 9.根据权利要求8所述的方法,其中,所述组织保存液为含有胎牛血清和蛋白酶抑制剂的无血清细胞冻存培养基。9. The method of claim 8, wherein the tissue preservation solution is a serum-free cell cryopreservation medium containing fetal bovine serum and protease inhibitors. 10.根据权利要求1、8或9所述的方法,其中,所述方法还包括:将消化后的样品与红细胞裂解液接触从而裂解红细胞,洗涤后获得分离的单细胞。10. The method according to claim 1, 8 or 9, wherein the method further comprises: contacting the digested sample with an erythrocyte lysing solution to lyse the erythrocytes, and washing to obtain isolated single cells.
CN201811595502.8A 2018-12-25 2018-12-25 Single celled method is separated from tissue Pending CN109666625A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811595502.8A CN109666625A (en) 2018-12-25 2018-12-25 Single celled method is separated from tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811595502.8A CN109666625A (en) 2018-12-25 2018-12-25 Single celled method is separated from tissue

Publications (1)

Publication Number Publication Date
CN109666625A true CN109666625A (en) 2019-04-23

Family

ID=66146064

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811595502.8A Pending CN109666625A (en) 2018-12-25 2018-12-25 Single celled method is separated from tissue

Country Status (1)

Country Link
CN (1) CN109666625A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110257318A (en) * 2019-05-27 2019-09-20 上海长海医院 A kind of preparation method of pancreas single cell suspension in mice with chronic pancreatitis
CN111088222A (en) * 2019-11-11 2020-05-01 广东国科细胞科技有限公司 A kind of preparation method of single cell suspension of adipose tissue
CN111549019A (en) * 2020-01-13 2020-08-18 北京航空航天大学 Method for preparing high-quality single cell suspension by remarkably improving plaque digestion
CN116536268A (en) * 2023-05-10 2023-08-04 杭州济扶科技有限公司 High-efficiency low-damage combined tumor tissue digestive juice and application thereof
CN116926050A (en) * 2023-07-18 2023-10-24 中国医学科学院北京协和医院 Digestive enzyme of tissue single cell suspension and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100150876A1 (en) * 2006-11-24 2010-06-17 Regents Of The Univeristy Of Minnesota Endodermal progenitor cells
CN108103013A (en) * 2018-01-26 2018-06-01 河北医科大学第四医院 The enzyme digestion original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell
CN108373994A (en) * 2018-01-26 2018-08-07 河北医科大学第四医院 The tissue block method's original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100150876A1 (en) * 2006-11-24 2010-06-17 Regents Of The Univeristy Of Minnesota Endodermal progenitor cells
CN108103013A (en) * 2018-01-26 2018-06-01 河北医科大学第四医院 The enzyme digestion original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell
CN108373994A (en) * 2018-01-26 2018-08-07 河北医科大学第四医院 The tissue block method's original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
侯晶岩: "《医学细胞生物学实验指导及习题集》", 31 August 2018, 汕头大学出版社 *
刘斌 等: "《细胞培养》", 31 January 2018, 世界图书出版公司 *
吴燕峰 等: "《实用医学细胞培养技术》", 31 January 2010, 中山大学出版社 *
李杨 等: "联合应用乌斯他丁和DNA酶提高分离胰岛的效果的实验研究", 《2012中国器官移植大会论文汇编》 *
苏泽轩 等: "《现代移植学》", 31 December 1998, 人民卫生出版社 *
袁世珍: "《胰腺癌》", 31 December 2001, 上海科学技术出版社 *
袁耀宗 等: "《消化系疾病临床新技术》", 28 February 2002, 人民军医出版社 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110257318A (en) * 2019-05-27 2019-09-20 上海长海医院 A kind of preparation method of pancreas single cell suspension in mice with chronic pancreatitis
CN110257318B (en) * 2019-05-27 2023-05-30 上海长海医院 A preparation method of pancreas single cell suspension in mice with chronic pancreatitis
CN111088222A (en) * 2019-11-11 2020-05-01 广东国科细胞科技有限公司 A kind of preparation method of single cell suspension of adipose tissue
CN111088222B (en) * 2019-11-11 2023-08-29 广东国科细胞科技有限公司 Preparation method of single-cell suspension of adipose tissue
CN111549019A (en) * 2020-01-13 2020-08-18 北京航空航天大学 Method for preparing high-quality single cell suspension by remarkably improving plaque digestion
CN116536268A (en) * 2023-05-10 2023-08-04 杭州济扶科技有限公司 High-efficiency low-damage combined tumor tissue digestive juice and application thereof
CN116926050A (en) * 2023-07-18 2023-10-24 中国医学科学院北京协和医院 Digestive enzyme of tissue single cell suspension and application thereof

Similar Documents

Publication Publication Date Title
CN109666644A (en) Single celled method is separated from tumor sample
CN109666625A (en) Single celled method is separated from tissue
CN112708610B (en) Mixed enzyme for skin tissue dissociation, preparation method thereof, dissociation kit and dissociation method
US20020192805A1 (en) Devices and methods for cell harvesting
CN109694845A (en) For separating single celled kit and its application
JPH02504222A (en) Methods for isolating subtype cell clusters from organs
CA2948952A1 (en) Process and device for isolating cells from biological tissue
CN109837235A (en) Application of the hydrogel microcarrier in the sticking, expand, freeze and digest of cell
CN109609439A (en) Methods of isolating single cells from abnormal tissues
WO1996034093A1 (en) Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells
CN112662614A (en) Kit and method for preparing pancreatitis tissue single cell suspension
CN109536449A (en) Single celled method is separated from abnormal structure
CN101848718A (en) The cell composition that is used for tissue regeneration
CN115851587A (en) Optimized culture medium, kit and culture method of human placenta-derived mesenchymal stem cells
Petrova et al. Novel thermostable serine collagenase from Thermoactinomyces sp. 21E: purification and some properties
CN104837987B (en) Detection of human umbilical cord tissue-derived cells
CN109628434A (en) It is single celled containing enzymatic compositions and its preparation method and application for separating
CN106801034A (en) A kind of Endometrial stem cell large-scale preparation method and its application
CN109666626A (en) Single celled method is separated from sample
CN109609438A (en) Methods for the isolation of single cells from non-tumor samples
CN115322964B (en) Construction method of 3D culture amniotic mesenchymal stem cell seed bank
CN109666624A (en) Kit and its application containing clostridiopetidase A
CN109694846A (en) Kit and its application containing trypsin inhibitor
CN109735515A (en) Composition and its preparation method and application containing clostridiopetidase A
EP3443068A1 (en) Non-enzymatic method and milling device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190423

RJ01 Rejection of invention patent application after publication